Search Results - "Cohn, D. R"

Refine Results
  1. 1

    Increased polyamines as protective disease modifiers in congenital muscular dystrophy by Kemaladewi, D U, Benjamin, J S, Hyatt, E, Ivakine, E A, Cohn, R D

    Published in Human molecular genetics (01-06-2018)
    “…Abstract Most Mendelian disorders, including neuromuscular disorders, display extensive clinical heterogeneity that cannot be solely explained by primary…”
    Get full text
    Journal Article
  2. 2

    Novel KDM6A (UTX) mutations and a clinical and molecular review of the X-linked Kabuki syndrome (KS2) by Banka, S., Lederer, D., Benoit, V., Jenkins, E., Howard, E., Bunstone, S., Kerr, B., McKee, S., Lloyd, I.C., Shears, D., Stewart, H., White, S.M., Savarirayan, R., Mancini, G.M.S., Beysen, D., Cohn, R.D., Grisart, B., Maystadt, I., Donnai, D.

    Published in Clinical genetics (01-03-2015)
    “…We describe seven patients with KDM6A (located on Xp11.3 and encodes UTX) mutations, a rare cause of Kabuki syndrome (KS2, MIM 300867) and report, for the…”
    Get full text
    Journal Article
  3. 3

    The SickKids Genome Clinic: developing and evaluating a pediatric model for individualized genomic medicine by Bowdin, S.C., Hayeems, R.Z., Monfared, N., Cohn, R.D., Meyn, M.S.

    Published in Clinical genetics (01-01-2016)
    “…Our increasing knowledge of how genomic variants affect human health and the falling costs of whole‐genome sequencing are driving the development of…”
    Get full text
    Journal Article
  4. 4

    Loss of sarcolemmal nNOS is common in acquired and inherited neuromuscular disorders by FINANGER HEDDERICK, E. L, SIMMERS, J. L, ANDRES-MATEOS, A. Soleimani E, MARX, R, FILES, D. C, KING, L, CRAWFORD, T. O, CORSE, A. M, COHN, R. D

    Published in Neurology (15-03-2011)
    “…Neuronal nitric oxide synthase (nNOS), normally expressed at the sarcolemmal membrane, is known to be mislocalized to the sarcoplasm in several forms of…”
    Get full text
    Journal Article
  5. 5

    Immunohistochemistry of affected tissue may guide cGVHD treatment decisions by Williams, K M, Ostrow, L W, Loeb, D M, Chung, T, Cohn, R D, Corse, A M, Mammen, A L, Chen, A R

    Published in Bone marrow transplantation (Basingstoke) (01-05-2012)
    “…Chronic graft-vs-host disease (cGVHD) myositis is a rare complication of hematopoietic SCT, for which the pathogenesis and optimal therapy are unclear. We…”
    Get full text
    Journal Article
  6. 6

    Emissions reductions using hydrogen from plasmatron fuel converters by Bromberg, L, Cohn, D.R, Rabinovich, A, Heywood, J

    Published in International journal of hydrogen energy (01-10-2001)
    “…Improvements in internal combustion engine and aftertreatment technologies are needed to meet future environmental quality goals. Systems using recently…”
    Get full text
    Journal Article
  7. 7

    System optimization and cost analysis of plasma catalytic reforming of natural gas by Bromberg, L., Cohn, D.R., Rabinovich, A., Alexeev, N., Samokhin, A., Ramprasad, R., Tamhankar, S.

    Published in International journal of hydrogen energy (01-12-2000)
    “…Plasma reforming could provide advantages in hydrocarbon reforming especially in small-to-medium-scale plants and in plants with fast transients. The…”
    Get full text
    Journal Article
  8. 8

    Plasma Reforming of Methane by Bromberg, L, Cohn, D. R, Rabinovich, A, O'Brie, C, Hochgreb, S

    Published in Energy & fuels (01-01-1998)
    “…Thermal plasma technology can be used in the production of hydrogen and hydrogen-rich gases from a variety of fuels. This paper describes experiments and…”
    Get full text
    Journal Article
  9. 9

    Compact plasmatron-boosted hydrogen generation technology for vehicular applications by Bromberg, L, Cohn, D.R, Rabinovich, A, Surma, J.E, Virden, J

    “…Onboard hydrogen generation using compact plasmatron devices could provide important new possibilities for reducing pollution from motor vehicles, making use…”
    Get full text
    Journal Article
  10. 10

    Plasma reformer-fuel cell system for decentralized power applications by Bromberg, L., Cohn, D.R., Rabinovich, A.

    “…A plasma-driven process is described for the reforming of hydrocarbon fuels into hydrogen-rich gases for use in fuel cells. High temperature non-catalytic…”
    Get full text
    Journal Article
  11. 11

    Association of nonsense mutation of dystrophin gene with disruption of sarcoglycan complex in X-linked dilated cardiomyopathy by Franz, Wolfgang-Michael, Muller, Matthias, Muller, Oliver J, Herrmann, Ralf, Rothmann, Thomas, Cremer, Marion, Cohn, Ronald D, Voit, Thomas, Katus, Hugo A

    Published in The Lancet (British edition) (20-05-2000)
    “…In a systematic analysis of inherited forms of cardiomyopathy, we previously identified a family with X-linked dilated cardiomyopathy characterised by a…”
    Get full text
    Journal Article
  12. 12

    Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies by Campbell, Kevin P, Michele, Daniel E, Barresi, Rita, Kanagawa, Motoi, Saito, Fumiaki, Cohn, Ronald D, Satz, Jakob S, Dollar, James, Nishino, Ichizo, Kelley, Richard I, Somer, Hannu, Straub, Volker, Mathews, Katherine D, Moore, Steven A

    Published in Nature (London) (25-07-2002)
    “…Muscle-eye-brain disease (MEB) and Fukuyama congenital muscular dystrophy (FCMD) are congenital muscular dystrophies with associated, similar brain…”
    Get full text
    Journal Article
  13. 13

    LARGE can functionally bypass α-dystroglycan glycosylation defects in distinct congenital muscular dystrophies by Campbell, Kevin P, Barresi, Rita, Michele, Daniel E, Kanagawa, Motoi, Harper, Hollie A, Dovico, Sherri A, Satz, Jakob S, Moore, Steven A, Zhang, Wenli, Schachter, Harry, Dumanski, Jan P, Cohn, Ronald D, Nishino, Ichizo

    Published in Nature medicine (01-07-2004)
    “…Several congenital muscular dystrophies caused by defects in known or putative glycosyltransferases are commonly associated with hypoglycosylation of…”
    Get full text
    Journal Article
  14. 14

    Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy by Campbell, Kevin P, Moore, Steven A, Saito, Fumiaki, Chen, Jianguo, Michele, Daniel E, Henry, Michael D, Messing, Albee, Cohn, Ronald D, Ross-Barta, Susan E, Westra, Steve, Williamson, Roger A, Hoshi, Toshinori

    Published in Nature (London) (25-07-2002)
    “…Fukuyama congenital muscular dystrophy (FCMD), muscle-eye-brain disease (MEB), and Walker-Warburg syndrome are congenital muscular dystrophies (CMDs) with…”
    Get full text
    Journal Article
  15. 15

    Dog allergen (Can f 1) and cat allergen (Fel d 1) in US homes: Results from the National Survey of Lead and Allergens in Housing by Arbes, Samuel J, Cohn, Richard D, Yin, Ming, Muilenberg, Michael L, Friedman, Warren, Zeldin, Darryl C

    Published in Journal of allergy and clinical immunology (01-07-2004)
    “…Exposures to dog and cat allergens are believed to play important roles in the etiology of asthma; however, the levels of these allergens have never been…”
    Get full text
    Journal Article
  16. 16

    National Prevalence and Exposure Risk for Cockroach Allergen in U.S. Households by Cohn, Richard D., Arbes, Samuel J., Jaramillo, Renee, Reid, Laura H., Zeldin, Darryl C.

    Published in Environmental health perspectives (01-04-2006)
    “…We characterized the prevalence of cockroach allergen exposure in a nationally representative sample of U.S. homes and assessed risk factors for elevated…”
    Get full text
    Journal Article
  17. 17

    Estimate of the Annual Number of Percutaneous Injuries Among Hospital‐Based Healthcare Workers in the United States, 1997–1998 by Panlilio, Adelisa L., Orelien, Jean G., Srivastava, Pamela U., Jagger, Janine, Cohn, Richard D., Cardo, Denise M.

    “…To construct a single estimate of the number of percutaneous injuries sustained annually by healthcare workers (HCWs) in the United States. Statistical…”
    Get full text
    Journal Article
  18. 18

    Disruption of Dag1 in Differentiated Skeletal Muscle Reveals a Role for Dystroglycan in Muscle Regeneration by Cohn, Ronald D., Henry, Michael D., Michele, Daniel E., Barresi, Rita, Saito, Fumiaki, Moore, Steven A., Flanagan, Jason D., Skwarchuk, Mark W., Robbins, Michael E., Mendell, Jerry R., Williamson, Roger A., Campbell, Kevin P.

    Published in Cell (06-09-2002)
    “…Striated muscle-specific disruption of the dystroglycan (DAG1) gene results in loss of the dystrophin-glycoprotein complex in differentiated muscle and a…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Economic Study of the Tunable Electron Beam Plasma Reactor for Volatile Organic Compound Treatment by Hadidi, K., Cohn, D.R., Vitale, S., Bromberg, L.

    “…A tunable electron beam generated plasma system has been developed for selective cold plasma treatment of dilute concentrations (1-3,000 ppm range) of…”
    Get full text
    Journal Article